Chroma Therapeutics is focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cancer and inflammation treatments.

Click to view Chroma's Pipeline

Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797

Chroma to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797